First Tracks Biotherapeutics (TRAX)
Oxford Ledge is still expanding full research coverage of TRAX. Fundamentals and analysis (and, signed in, a delayed quote) are available in the app; the SEC-sourced material below is what we currently have indexed here.
SEC filings
- 10-Q Quarterly financial report (unaudited) 2026-05-14
- 8-K Results of operations / financial condition; Financial statements and exhibits 2026-05-14
- S-1 IPO / securities registration statement 2026-05-08
- 8-K Entry into material agreement; Completion of acquisition or disposition; 3.02; 3.03; 5.01; Departure/election of directors or officers; Amendments to articles or bylaws; Other material event; Financial statements and exhibits 2026-04-20
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-04-03
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for TRAX. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open TRAX in Oxford Ledge — fundamentals, filings, and analysis in the app.
- Browse the stock directory
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Fundamentals are available in the app.